Details for Patent: 7,405,223

Summary for Patent: 7,405,223

Title:	Treating allergic and inflammatory conditions
Abstract:	A method of treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages, e.g. seasonal allergic rhinitis, perennial allergic rhinitis, or chronic idopathic urticaria, in a human more 12 years old, by administering an amount of desloratadine, e.g. 2.times.2.5 mg or 5 mg/day for a time sufficient to produce a geometric mean steady state maximum plasma concentration of desloratadine in the range of about 2.90 ng/mL to about 4.54 ng/mL, or a arithmetic mean steady state maximum plasma concentration of desloratadine in the range of about 3.2 ng/mL to about 5.0 ng/mL is disclosed.
Inventor(s):	Affrime; Melton B. (Warren, NJ), Banfield; Christopher R. (High Bridge, NJ), Gupta; Samir K. (East Brunswick, NJ), Padhi; Desmond (Thousand Oaks, CA)
Assignee:	Schering Corporation (Kenilworth, NJ)
Application Number:	09/760,588
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 7,405,223

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 7,405,223

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	027937
Australia	3325901
Canada	2398264
European Patent Office	1251852
Japan	2003528823